Moors & Cabot, Inc. View Ray, Inc. Transaction History

Moors & Cabot, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.35 - $3.28 $2,625 - $24,600	-7,500 Reduced 37.5%	12,500 $4,000
Q4 2022 Feb 09, 2023	BUY	$3.65 - $4.82 $73,000 - $96,400	20,000 New	20,000 $89,000
Q2 2022 Aug 08, 2022	BUY	$2.42 - $4.05 $48,400 - $81,000	20,000 New	20,000 $53,000
Q3 2020 Nov 09, 2020	SELL	$2.12 - $3.53 $21,200 - $35,300	-10,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.66 - $2.73 $16,600 - $27,300	10,000 New	10,000 $22,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.